Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents
    2.
    发明申请
    Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents 失效
    抑制胆碱酯酶并释放药理学活性剂的氨基甲酰酯

    公开(公告)号:US20050096387A1

    公开(公告)日:2005-05-05

    申请号:US10969796

    申请日:2004-10-19

    Abstract: Carbamoyl esters inhibit cholinesterase activity and, upon hydrolysis release a pharmacologically active agent. In one embodiment, the carbamoyl ester has the following structure: wherein A is selected from the group consisting of an unsubstituted aryl, a substituted aryl, an unsubstituted heteroaryl and a substituted heteroaryl. The carbamoyl esters are employed in methods to treat an individual. The pharmacologically active agent obtained by hydrolysis of the carbamoyl esters can treat, for example, a nervous system condition, a cholinergic deficiency and conditions or diseases associated with a deficiency in a pharmacologically active agent, such as acetylcholine.

    Abstract translation: 氨基甲酰酯抑制胆碱酯酶活性,并且在水解时释放药理活性剂。 在一个实施方案中,氨基甲酰酯具有以下结构:其中A选自未取代的芳基,取代的芳基,未取代的杂芳基和取代的杂芳基。 氨基甲酰酯用于治疗个体的方法。 通过水解氨基甲酰酯获得的药理学活性剂可以治疗例如神经系统状况,胆碱能缺乏以及与药理活性剂如乙酰胆碱缺乏相关的病症或疾病。

Patent Agency Ranking